Black Rock Inc. Horizon Therapeutics Public LTD CO Transaction History

Black Rock Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $3.22 Million - $3.76 Million	-32,505 Reduced 0.22%	14,871,176 $1.72 Billion
Q2 2023 Aug 11, 2023	SELL	$96.34 - $112.38 $2.97 Million - $3.46 Million	-30,807 Reduced 0.21%	14,903,681 $1.53 Billion
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $15 Million - $15.9 Million	139,677 Added 0.94%	14,934,488 $1.63 Billion
Q4 2022 Feb 13, 2023	SELL	$62.39 - $113.8 $51.4 Million - $93.8 Million	-824,212 Reduced 5.28%	14,794,811 $1.68 Billion
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $60.1 Million - $86.4 Million	1,020,576 Added 6.99%	15,619,023 $967 Million

Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $60.6 Million - $88.8 Million	762,840 Added 5.51%	14,598,447 $1.16 Billion
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $71.5 Million - $90.9 Million	827,583 Added 6.36%	13,835,607 $1.46 Billion
Q4 2021 Feb 10, 2022	SELL	$98.56 - $119.91 $50.1 Million - $60.9 Million	-508,152 Reduced 3.76%	13,008,024 $1.4 Billion
Q3 2021 Nov 09, 2021	SELL	$91.91 - $110.37 $43.2 Million - $51.9 Million	-470,556 Reduced 3.36%	13,516,176 $1.48 Billion
Q2 2021 Aug 11, 2021	BUY	$86.24 - $95.92 $1.21 Billion - $1.34 Billion	13,986,732 New	13,986,732 $1.31 Billion

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.